Novelix Pharmaceuticals Ltd

Novelix Pharma. Summary Chart Analysis Peers Quarters Profit & Loss Balance Sheet Cash Flow Ratios Investors Documents

Novelix Pharmaceuticals Ltd

₹ 61.0 -3.05%
20 Feb - close price
trimurthidrugs.com BSE: 536565
About

Incorporated in 1994, Novelix Pharmaceuticals Ltd trades in Pharmaceuticals and related products , shares, and securities[1]

Key Points

Business Overview:[1][2][3]
NPL is a recent entrant in the life sciences research and pharmaceutical intermediates business. In FY24, the company altered its objectives to expand into the pharmaceutical bulk drug segment and healthcare research, analytics, and technology. Currently, it is engaged in pharmaceutical research and the production and trading of bulk drugs (Active Pharmaceutical Ingredients) as well as key starting materials and intermediates.

Website BSE
  • Market Cap ₹ 122 Cr.
  • Current Price ₹ 61.0
  • High / Low ₹ 70.2 / 25.4
  • Stock P/E 66.9
  • Book Value ₹ 14.9
  • Dividend Yield 0.00 %
  • ROCE 0.96 %
  • ROE 0.64 %
  • Face Value ₹ 10.0
Edit ratios

Pros

  • Company is almost debt free.

Cons

  • Stock is trading at 4.10 times its book value
  • Though the company is reporting repeated profits, it is not paying out dividend
  • Promoter holding has decreased over last quarter: -2.53%
  • Company has a low return on equity of 0.11% over last 3 years.
  • Company has high debtors of 216 days.

* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.

Peer comparison

Healthcare Healthcare Healthcare Services Healthcare Research, Analytics & Technology

Edit Columns
Loading peers table ...

Quarterly Results

Standalone Figures in Rs. Crores / View Consolidated

Dec 2022 Mar 2023 Jun 2023 Sep 2023 Dec 2023 Mar 2024 Jun 2024 Sep 2024 Dec 2024 Mar 2025 Jun 2025 Sep 2025 Dec 2025
0.43 0.87 1.95 0.93 0.50 0.84 0.60 3.96 5.30 20.86 22.35 36.36 48.40
0.52 1.07 2.14 1.04 0.61 0.69 1.04 3.74 5.17 20.63 22.17 35.66 47.09
Operating Profit -0.09 -0.20 -0.19 -0.11 -0.11 0.15 -0.44 0.22 0.13 0.23 0.18 0.70 1.31
OPM % -20.93% -22.99% -9.74% -11.83% -22.00% 17.86% -73.33% 5.56% 2.45% 1.10% 0.81% 1.93% 2.71%
0.18 0.23 0.05 0.05 0.09 0.13 0.10 -0.08 0.00 0.00 0.00 0.03 0.00
Interest 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Depreciation 0.02 0.01 0.01 0.01 0.01 0.01 0.00 0.00 0.00 0.02 0.01 0.01 0.03
Profit before tax 0.07 0.02 -0.15 -0.07 -0.03 0.27 -0.34 0.14 0.13 0.21 0.17 0.72 1.28
Tax % 0.00% 0.00% 6.67% 0.00% 0.00% 0.00% 2.94% 0.00% -15.38% 14.29% 41.18% 26.39% 21.88%
0.07 0.01 -0.17 -0.07 -0.03 0.28 -0.35 0.13 0.15 0.18 0.11 0.53 1.00
EPS in Rs 0.09 0.01 -0.21 -0.09 -0.04 0.35 -0.35 0.13 0.15 0.18 0.09 0.37 0.58
Raw PDF

Profit & Loss

Standalone Figures in Rs. Crores / View Consolidated

Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025 TTM
6 1 1 4 3 4 2 1 1 2 4 31 128
5 1 1 3 3 3 1 4 3 2 4 31 126
Operating Profit 1 0 0 0 0 0 0 -3 -2 0 -0 0 2
OPM % 16% 33% 43% 5% 15% 6% 12% -244% -151% 0% -6% 0% 2%
0 0 0 0 -0 0 0 0 0 0 0 0 0
Interest 0 0 0 0 0 0 0 0 0 0 0 0 0
Depreciation 0 0 0 0 0 0 0 0 0 0 0 0 0
Profit before tax 1 0 0 0 0 0 0 -3 -2 -0 0 0 2
Tax % 32% 88% 31% 24% 34% -32% 20% 0% -1% 0% 50% 33%
0 0 0 0 0 0 0 -3 -2 -0 0 0 2
EPS in Rs 0.52 0.02 0.12 0.19 0.22 0.31 0.11 -4.04 -1.93 -0.07 0.01 0.08 1.22
Dividend Payout % 0% 0% 0% 0% 0% 0% 0% 0% 0% 0% 0% 0%
Compounded Sales Growth
10 Years: 36%
5 Years: 83%
3 Years: 200%
TTM: 1096%
Compounded Profit Growth
10 Years: 15%
5 Years: -2%
3 Years: 27%
TTM: 767%
Stock Price CAGR
10 Years: 21%
5 Years: 66%
3 Years: 85%
1 Year: 141%
Return on Equity
10 Years: -4%
5 Years: -11%
3 Years: 0%
Last Year: 1%

Balance Sheet

Standalone Figures in Rs. Crores / View Consolidated

Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025 Sep 2025
Equity Capital 8 8 8 8 8 8 8 8 8 8 8 10 14
Reserves 3 3 3 3 4 4 4 1 -1 -1 -1 8 11
0 0 0 0 0 0 0 0 0 0 0 0 0
0 0 0 0 0 0 0 0 0 0 0 10 46
Total Liabilities 12 12 12 12 12 12 12 9 7 7 7 27 72
1 1 1 1 1 0 0 0 2 0 0 0 1
CWIP 0 0 0 0 0 0 0 0 0 0 0 0 0
Investments 0 1 3 2 3 3 4 4 1 3 3 0 0
10 9 8 9 9 9 8 5 5 4 4 27 71
Total Assets 12 12 12 12 12 12 12 9 7 7 7 27 72

Cash Flows

Standalone Figures in Rs. Crores / View Consolidated

Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
0 -0 2 -1 1 -0 1 1 1 -2 -0 -14
0 -0 -2 1 -1 0 -0 0 0 0 0 3
-0 -0 0 0 0 0 0 0 0 0 0 11
Net Cash Flow 0 -1 0 -0 -0 0 1 1 1 -2 -0 1

Ratios

Standalone Figures in Rs. Crores / View Consolidated

Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
Debtor Days 54 30 4 40 130 216 19 25 32 36 1 216
Inventory Days 28 0 28 19 13 39 89 239 222 113 10
Days Payable 4 0 54 13 5 4 0 14 0 115
Cash Conversion Cycle 77 30 4 68 95 216 54 111 271 244 114 111
Working Capital Days 571 2,225 2,584 863 932 858 1,711 819 647 743 346 197
ROCE % 5% 1% 1% 1% 3% 1% 1% -31% -19% -1% 0% 1%

Shareholding Pattern

Numbers in percentages

1 Recently
Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Jan 2026
66.92% 66.92% 66.92% 66.92% 66.54% 66.56% 66.56% 66.56% 52.75% 53.33% 51.97% 50.79%
33.08% 33.08% 33.08% 33.08% 33.46% 33.44% 33.45% 33.44% 47.25% 46.66% 48.01% 49.22%
No. of Shareholders 2,3912,3892,6212,6352,5692,5332,5022,4842,4082,6972,9942,997

Documents

Announcements

Annual reports